RT Journal Article
SR Electronic
T1 Therapeutic journey of patients affected by stroke: cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.09.23296782
DO 10.1101/2023.10.09.23296782
A1 Santos de Mendonça, Marcirene
A1 de Paula, Caio Lopes Pinheiro
A1 Santos, Douglas dos
A1 da Silva, Marcelo Nunes
A1 Júlia Oliveira Ramos, Maria
A1 de Magalhães Soares Pinheiro, Fernanda Gomes
YR 2023
UL http://medrxiv.org/content/early/2023/10/10/2023.10.09.23296782.abstract
AB The therapeutic journey of patients affected by a stroke cause health impacts and deaths. Stroke is an acute neurological dysfunction, classified as hemorrhagic or ischemic. This study aimed to compare the therapeutic journey in the access of patients affected by stroke in hospitals in the Brazilian Northeast.Prospective cohort study, carried in all public hospitals that had a neuroimaging service in the State of Sergipe. The collection instrument sought sociodemographic characterization and timeline. The data were exported to the R Core Team 2022 software. After being coded and tabulated, they were analyzed using descriptive statistics. The hypothesis of independence was tested using Pearson Chi-Square and Fisher Exact tests.A total of 159 patients cared for in the hinterland region of the State and 91 in the capital city (Aracaju) participated in the study, with a median age of 66 years old (SD:55.5-75) in the capital and with a median age of 72 years old (SD:60-82) in the hinterland. There was a predominance in females, 76.6% and 64.1%, respectively. It was found a higher incidence of the ischemic stroke (IS) (p<0.002). The decision time between the onset of signs and symptoms and the decision to call up transportation, it was observed that patients with IS cared for in the hinterland take three times longer (p=0.002). Regarding the time between the stroke detection and the CT scan, it was five times longer for those from the hinterland (p<0.001) in cases of IS. In cases of HS, the time was 1.4 longer for those from the hinterland. Concerning the neurological evaluation, in cases of IS and HS, the rates found were 76.6% vs 78.3% in the hinterland, while 100% of patients were evaluated for both types of stroke episodes in the capital city (p<0.001).The therapeutic journey of patients cared for in the hinterland of the State has a longer period of time.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNoneFunding StatementThis research did not receive any specific grant from public, commercial or non-profit funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved on June 7, 2022, by the Research Ethics Committee of Faculdade Estácio de Sergipe - Estácio Phase, with a favorable opinion under number 2.830.187.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesI, Marcirene Santos de Mendonça, declare that I am available to provide all necessary data to Revista Stroke as requested. I commit to making all relevant information available as quickly as possible, ensuring its quality and accuracy. I am aware of the importance of data for the development of research, and I recognize that my collaboration is fundamental to its success. Therefore, I am at your disposal to provide any necessary information, as well as to answer any questions or additional requests. I further declare that all data provided is reliable and corresponds to reality, being in compliance with the laws and regulations applicable to the protection of personal data and privacy. I assume full responsibility for the security and confidentiality of the data provided, committing myself not to share it with third parties without due authorization or specific purpose previously agreed. I am aware that if there is any change in my data availability, I must immediately inform Revista Stroke.